Optimus concludes Molnupiravir Phase 3 Clinical Trial study
The company aims to develop a cutting-edge and affordable treatment option for COVID-19 and neutralise the disease in minimum treatment duration
Source: biospectrumindia.com
Page 2 - Central Licensing News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Central Licensing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Central Licensing Today - Breaking & Trending Today
How India's regulatory pitfalls helped Covishield and Covaxin get rapid approval
Text Size: A+ The year 2021 in India began with a flurry of events around the Covid-19 vaccine. The Indian government conducted dry runs for the vaccines, and two vaccines Covishield (Oxford University-AstraZeneca) and Covaxin (Bharat Biotech) were granted accelerated regulatory approval by the Central Drugs Standard Control Organisation (CDSCO). The process of granting these vaccines regulatory approval has been a subject of intense scrutiny. The grant of these approvals and the scrutiny involved in the process has been marred with several concerns as these vaccines are yet to complete ...
Source: theprint.in
Bharat Biotech Obtains Central Licensing Authority's Permission To Manufacture And Sell COVAXIN
Bharat Biotech obtains Central Licensing Authority's permission to manufacture and sell COVAXIN The firm will have to submit safety data with due analysis every 15 days for 2 months and monthly thereafter. January 04, 2021 / 07:12 AM IST The Central Licensing authority has issued permission to Bharat Biotech to manufacture pharmaceutical formulation of a new drug-- COVAXIN for sale or distribution on January 3. The firm will have to submit safety data with due analysis every 15 days for 2 months and monthly thereafter. It will also have to submit a risk management plan and provide a proto...
Source: moneycontrol.com